---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023097"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:31:16.253888+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience Announces Results of 2024 Annual Meeting, Stockholders Approve Reverse Split Authorization

## Summary
- Re-elected directors Jessica D. Grossman, M.D. (28,626,331 for) and Susan L. Kelley, M.D. (28,623,481 for) as Class I directors.
- Ratified Haskell & White LLP as independent auditor for FY2024 with 53,420,221 votes for, 1,624,718 against.
- Advisory approval of named executive officer compensation received 26,182,433 votes for, 3,556,256 against, 594,264 abstentions.
- Approved reverse stock split authorization at ratio between 1-for-2 and 1-for-12, with 42,657,404 for, 10,792,335 against.
- Approved meeting adjournment proposal to solicit additional proxies if needed, with 44,780,743 votes for.

## SEC filing metadata
- accession: 0001493152-24-023097
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315224023097/0001493152-24-023097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315224023097/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023097
- JSON: https://secwatch.observer/filing/0001493152-24-023097.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023097.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.